1. Regenacy Pharmaceuticals Appoints Dr. William W. Chin to Board of Directors and Scientific ...

    Regenacy Pharmaceuticals Appoints Dr. William W. Chin to Board of Directors and Scientific ...

    WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, announced today the appointment of William (Bill) W. Chin, M.D., to its Board of Directors and ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Bill is a world-renowned molecular endocrinologist who has pioneered the understanding of the mechanisms of nuclear receptor action. His expertise will be instrumental to Regenacy as we prepare to enter Phase II clinical trials in diabetic peripheral neuropathy later this year.
    2. We are thrilled to welcome Dr. Chin to Regenacy's Board of Directors and Scientific Advisory Board.
    3. I am honored to join this exceptional team and have the opportunity to advise the company as it continues to develop a pipeline of transformative treatments that go beyond analgesia to address the multiple complex issues underlying peripheral neuropathy, particularly those complicating longstanding diabetes mellitus.
  3. Topics Mentioned